Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | ACHE | P22303 | 2/20 | 0.35 |
| ▸ | TPMT | P51580 | 1/20 | 0.33 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.32 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.32 |
| ▸ | C1S | P09871 | 1/20 | 0.32 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.32 |
| ▸ | SELL | P14151 | 1/20 | 0.32 |
| ▸ | SELP | P16109 | 1/20 | 0.32 |
| ▸ | SELE | P16581 | 1/20 | 0.32 |
| ▸ | RAPGEF4 | Q8WZA2 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28897210 | 0.78 | ALDH1A1 (0.40) | ALDH1A1TSHRACHETPMTPRSS1 | |
| SCHEMBL26115 | 0.73 | — | — | |
| SCHEMBL341533 | 0.73 | ALDH1A1 (0.67) | ALDH1A1TSHRACHETPMTPRSS1 | |
| SCHEMBL503226 | 0.72 | ALDH1A1 (0.47) | ALDH1A1TSHRACHETPMTPRSS1 | |
| SCHEMBL8013123 | 0.71 | ACHE (0.50) | ALDH1A1TSHRACHETDP1 | |
| SCHEMBL8373256 | 0.69 | ALDH1A1 (0.44) | ALDH1A1TSHRACHETPMTPRSS1 | |
| SCHEMBL2229713 | 0.69 | ALDH1A1 (0.44) | ALDH1A1TSHRACHETPMTPRSS1 | |
| SCHEMBL23202757 | 0.69 | ALDH1A1 (0.61) | ALDH1A1TSHRACHETPMTPRSS1 | |
| SCHEMBL25403949 | 0.69 | ALDH1A1 (0.61) | ALDH1A1TSHRACHETPMTPRSS1 | |
| Hydrochloric Acid SCHEMBL2443762 | 0.69 | ALDH1A1 (0.61) | ALDH1A1TSHRACHETPMTPRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120214999-A1 | METAL COMPLEX, PYRIDYLPHOSPHINE COMPOUND, AND METHOD FOR PRODUCING ALKYL METHACRYLATE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-08-23 | — | — | US | disclosed |
| EP-2487179-A1 | METAL COMPLEX, PYRIDYLPHOSPHINE COMPOUND, AND METHOD FOR PRODUCING ALKYL METHACRYLATE | Sumitomo Chemical Co., Ltd (JP) | 2012-08-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120214999-A1 | METAL COMPLEX, PYRIDYLPHOSPHINE COMPOUND, AND METHOD FOR PRODUCING ALKYL METHACRYLATE | AP1M1, MPHOSPH6, MACO1 | ALDH1A1 2811/4885TSHR 4468/4885ACHE 974/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.